Articles Archive - Page 446 of 456 - JDDonline - Journal of Drugs in Dermatology

Dec 10

ARTICLE: Efficacy of Ceramide-Containing Formulations on UV-Induced Skin Surface Barrier Alterations

By No Comments

INTRODUCTIONThe epidermis, the skinâ€™s outermost layer, functions as a barrier against environmental aggressors through the cornification of keratinocytes to form the stratum corneum (SC). Embedded within a lipid matrix that…

Dec 10

Love0

Topical Metronidazole After Discontinuation of Oral Metronidazole for Continuing Treatment of Lichen Planus

By No Comments

Cutaneous Lichen Planus affects 0.2–1% of adults worldwide, primarily between 30–60, with a 3:2 female predominance. Despite an association with HCV, and a possible role for contact allergens, pathogenesis remains…

Dec 10

Love0

Full Face and Neck Treatment With OnabotulinumtoxinA in Patients With Facial Palsy

By No Comments

INTRODUCTIONFacial palsy is a common problem from which many patients do not completely recover and hence have to live with chronic sequelae.1 These may include discomfort, functional deficiencies, and aesthetic…

Dec 10

Love0

Influence of Rheological Properties and Needle Size on Extrusion Forces of Hyaluronic Acid Based Soft Tissue Fillers

By No Comments

INTRODUCTIONMore than 1 billion US dollars were spent in 2018 on treatments with injectable agents like neuromodulators or soft tissue fillers for aesthetic purposes according to the annual statistic report…

Dec 10

Love0

Two Cases of Recalcitrant Dyshidrotic Eczema Treated With Dupilumab

By No Comments

INTRODUCTIONDyshidrotic eczema, also known as dyshidrosis or pompholyx when involving larger bullae, is a chronic, relapsing palmoplantar dermatosis characterized by intensely pruritic and frequently painful deep-seated vesicles and bullae. Often…

Dec 10

Love0

A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor

By No Comments

INTRODUCTIONBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive malignancy caused by transformed plasmacytoid dendritic cells that overexpress interleukin-3 receptor subunit alpha (IL3RA) also known as CD123.1 Tagraxofusp-erzs…

Dec 10

Love0

FULL SUPPLEMENT: Skin Barrier and Skin Health

By No Comments

In this supplement:Efficacy of Ceramide-Containing Formulations on UV-Induced Skin Surface Barrier Alterations The human skin, particularly the stratum corneum, serves as a protective barrier against exogenous factors, including ultraviolet radiation…

Dec 10

Love0

Prospective Clinical Trial Evaluating the Long-Term Safety and Efficacy of Calcium Hydroxylapatite for Chest Rejuvenation

By No Comments

INTRODUCTIONThe use of dermal fillers is the second most prevalent, minimally invasive aesthetic procedure performed in the United States, reaching 2.6 million in 2018.1 Among the available dermal fillers, calcium…

Dec 10

Love0

Management of Primary Focal Hyperhidrosis: An Algorithmic Approach

By No Comments

INTRODUCTIONHyperhidrosis (HH) is a disorder of excessive perspiration that exceeds the level required for physiological temperature regulation. Sweat is produced by both eccrine and apocrine glands in the skin. Eccrine…

Dec 10

Love0

Randomized, Double-Blind, Placebo-Controlled Study of Poly-L-Lactic acid for Treatment of Cellulite in the Lower Extremities

By No Comments

INTRODUCTIONCellulite is an aesthetic condition associated with distress, dissatisfaction and reduced quality of life in 85% to 98% of post-pubertal women. The etiology of cellulite remains elusive, with various pathophysiological…

Dec 10

Love0

FULL SUPPLEMENT: Status Update: Isotretinoin

By No Comments

In this supplement: Why Absorica LD? For close to four decades, isotretinoin has been a mainstay treatment for severe nodular acne. It was the first and still remains the only…

Dec 10

Love0

ARTICLE: Why Absorica LD?

By No Comments

For close to four decades, isotretinoin has been a mainstay treatment for severe nodular acne. It was the first and still remains the only oral therapy shown to address all…

ARTICLE: Efficacy of Ceramide-Containing Formulations on UV-Induced Skin Surface Barrier Alterations

Topical Metronidazole After Discontinuation of Oral Metronidazole for Continuing Treatment of Lichen Planus

Full Face and Neck Treatment With OnabotulinumtoxinA in Patients With Facial Palsy

Influence of Rheological Properties and Needle Size on Extrusion Forces of Hyaluronic Acid Based Soft Tissue Fillers

Two Cases of Recalcitrant Dyshidrotic Eczema Treated With Dupilumab

A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor

FULL SUPPLEMENT: Skin Barrier and Skin Health

Prospective Clinical Trial Evaluating the Long-Term Safety and Efficacy of Calcium Hydroxylapatite for Chest Rejuvenation

Management of Primary Focal Hyperhidrosis: An Algorithmic Approach

Randomized, Double-Blind, Placebo-Controlled Study of Poly-L-Lactic acid for Treatment of Cellulite in the Lower Extremities

FULL SUPPLEMENT: Status Update: Isotretinoin

ARTICLE: Why Absorica LD?

Search page

Advertisement

Popular

Advertisement

News Topics

News Topics

Journal of Drugs in Dermatology

Search